Nurofen Miesnie I Stawy Forte (Ibuprofen Sodium Dihydrate)

Ibuprofen sodium dihydrate acts as an anti‑inflammatory and analgesic across several musculoskeletal indications.

• Osteoarthritis: helps reduce joint pain and improve mobility.
• Rheumatoid arthritis: lessens inflammation and stiffness in affected joints.
• Acute musculoskeletal injury: provides pain relief and decreases swelling after sprains or strains.

• Ibuprofen sodium dihydrate inhibits cyclo‑oxygenase (COX‑1 and COX‑2) enzymes, decreasing the synthesis of prostaglandins that mediate pain, inflammation and fever. By reducing prostaglandin levels, it diminishes peripheral sensitisation of nociceptors and limits inflammatory exudate formation, producing analgesic and anti‑inflammatory effects.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects

• Dyspepsia: mild stomach discomfort or heartburn.
• Nausea: feeling of queasy stomach.
• Headache: transient head pain.
• Dizziness: light‑headed sensation.
• Rash: mild skin irritation.

Serious or Rare Side Effects

• Gastrointestinal ulceration or bleeding.
• Renal impairment: reduced kidney function.
• Hepatic injury: elevated liver enzymes or hepatitis.
• Severe hypersensitivity: anaphylaxis or angio‑edema.
• Cardiovascular events: increased risk of heart attack or stroke.

Before initiating therapy, consider the following safety measures:

• Assess renal function: evaluate baseline kidney health, especially in the elderly.
• Evaluate hepatic status: check liver function tests if pre‑existing liver disease is present.
• Review cardiovascular risk: use cautiously in patients with known heart disease.
• Avoid concurrent NSAIDs: limit additive gastrointestinal toxicity.
• Monitor for gastrointestinal symptoms: advise patients to report persistent pain or bleeding.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Ibuprofen may interact with several drug classes, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): heightened bleeding risk.
• High‑dose aspirin: increased gastrointestinal toxicity.
• Selective COX‑2 inhibitors: additive renal and cardiovascular effects.

Moderate Interactions (Monitor Closely)

• ACE inhibitors or ARBs: possible reduction in antihypertensive effect and renal function.
• Diuretics: risk of reduced kidney perfusion.
• Lithium: increased lithium serum concentrations.
• Methotrexate: decreased renal clearance leading to toxicity.